Treatment and outcome of stage XXXX squamous cell carcinoma of the uterine cervix.

@entity1 @entity9216 @entity66 @entity957 @entity5436
OBJECTIVE: To evaluate the treatment and clinical outcome of @entity1 with FIGO stage @entity9216 @entity957 (SCC). METHODS: Medical records, including 5-year follow-up, were reviewed for 276 @entity1 with stage @entity9216 SCC. RESULTS: As definitive surgery, 152 (55.1%), 72 (26.1%), 40 (14.5%), and 12 (4.3%) @entity1 underwent conization, hysterectomy, hysterectomy with pelvic lymphadenectomy (PL), and radical hysterectomy with PL, respectively. Among these groups, the 5-year recurrence-free rate was 94.1%, 98.6%, 95%, and 100%, respectively, and the survival rate was 98.7%, 98.6%, 100%, and 100%, respectively. @entity66 was identified among 12 (4.3%) @entity1 , and was related to the depth of invasion (P<0.001). Eleven (4.0%) of 276 @entity1 were found to have lymph vascular space invasion (LVSI). There were no positive lymph nodes among 52 @entity1 who underwent PL, including those with LVSI. Conization was followed by hysterectomy in 49 @entity1 . In these @entity1 , @entity5436 was found in 18 @entity1 , 3 of whom had no involved margins on previous conization. In the group of @entity1 treated by conization, recurrence correlated with the status of the endocervical and lateral cone margin (P<0.001). CONCLUSION: As a conservative approach, conization is an effective and reasonable treatment option for stage @entity9216 SCC, especially in actively reproductive @entity1 .
